Loading…
Development of Spin-Labeled Probes for Adenosine Receptors
Functionalized xanthine derivatives bearing a nitroxide moiety at the 3- or 8-position were synthesized as electron paramagnetic resonance (EPR) probes. The 8-cyclopentyl-1-propylxanthine derivative 4, spin-labeled at N3 by substitution with a nitroxide-bearing dihydropyrrole moiety, was a potent an...
Saved in:
Published in: | Journal of medicinal chemistry 2005-03, Vol.48 (6), p.2108-2114 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-a381t-9a96fa87c6890d9c461fb44527233271e2f22a9cfc6775048c120d9ef04633a23 |
---|---|
cites | cdi_FETCH-LOGICAL-a381t-9a96fa87c6890d9c461fb44527233271e2f22a9cfc6775048c120d9ef04633a23 |
container_end_page | 2114 |
container_issue | 6 |
container_start_page | 2108 |
container_title | Journal of medicinal chemistry |
container_volume | 48 |
creator | Ilaš, Janez Pečar, Slavko Hockemeyer, Jörg Euler, Harald Kirfel, Armin Müller, Christa E |
description | Functionalized xanthine derivatives bearing a nitroxide moiety at the 3- or 8-position were synthesized as electron paramagnetic resonance (EPR) probes. The 8-cyclopentyl-1-propylxanthine derivative 4, spin-labeled at N3 by substitution with a nitroxide-bearing dihydropyrrole moiety, was a potent and selective A1 adenosine receptor antagonist (K i for A1 5.5 nM, 1600-fold selectivity vs A2A, >200-fold vs A2B, and 310-fold vs A3 adenosine receptors). 8-(1-Oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)-1,3-dipropylxanthine 10 (K i for A1 8.2 nM) was similarly potent and selective, while 8-(1-oxyl-2,2,6,6-tetramethylpiperidin-4-yl)-1,3-dipropylxanthine 11 (K i for A1 160 nM) exhibited significantly lower affinity for A1 adenosine receptors. 8-[4-(((1-Oxyl-2,2,6,6-tetramethylpiperidin-4-yl)amino)-2-oxoethoxy)phenyl]-1-propylxanthine 14, a 3-unsubstituted xanthine derivative, was found to be a potent A2B adenosine receptor antagonist (K i for A2B 48 nM) but also exhibited high affinity for A1 receptors (K i for A1 15.7 nM). An X-ray structure of compound 10 was obtained, confirming the proposed structure. The novel spin-labeled A1-selective or A1/A2B-nonselective adenosine receptor antagonists may become useful probes for biophysicochemical investigations of adenosine receptors in their membrane environment. |
doi_str_mv | 10.1021/jm049513x |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67528505</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67528505</sourcerecordid><originalsourceid>FETCH-LOGICAL-a381t-9a96fa87c6890d9c461fb44527233271e2f22a9cfc6775048c120d9ef04633a23</originalsourceid><addsrcrecordid>eNpt0EtLw0AUBeBBFFsfC_-AZKPgIjrvSdwV31LR2orLYTq9A6lJJs6kov_eSEu7cXUX9-NwOAgdEXxOMCUX8wrzXBD2vYX6RFCc8gzzbdTHmNKUSsp6aC_GOcaYEcp2UY8IpQgXrI8ur-ELSt9UULeJd8m4Kep0aKZQwix5CX4KMXE-JIMZ1D4WNSSvYKFpfYgHaMeZMsLh6u6jt9ubydV9Ony-e7gaDFPDMtKmucmlM5myMsvxLLdcEjflXFBFGaOKAHWUmtw6K5USmGeW0M6Bw1wyZijbR6fL3Cb4zwXEVldFtFCWpga_iFoqQTOBRQfPltAGH2MAp5tQVCb8aIL131B6PVRnj1ehi2kFs41cLdOBkxUw0ZrSBVPbIm6clEJw8ufSpStiC9_rvwkfXTGmhJ68jPXkKX8c3Y9y_b7JNTbquV-Eutvun4K_1Z-JMQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67528505</pqid></control><display><type>article</type><title>Development of Spin-Labeled Probes for Adenosine Receptors</title><source>American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list)</source><creator>Ilaš, Janez ; Pečar, Slavko ; Hockemeyer, Jörg ; Euler, Harald ; Kirfel, Armin ; Müller, Christa E</creator><creatorcontrib>Ilaš, Janez ; Pečar, Slavko ; Hockemeyer, Jörg ; Euler, Harald ; Kirfel, Armin ; Müller, Christa E</creatorcontrib><description>Functionalized xanthine derivatives bearing a nitroxide moiety at the 3- or 8-position were synthesized as electron paramagnetic resonance (EPR) probes. The 8-cyclopentyl-1-propylxanthine derivative 4, spin-labeled at N3 by substitution with a nitroxide-bearing dihydropyrrole moiety, was a potent and selective A1 adenosine receptor antagonist (K i for A1 5.5 nM, 1600-fold selectivity vs A2A, >200-fold vs A2B, and 310-fold vs A3 adenosine receptors). 8-(1-Oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)-1,3-dipropylxanthine 10 (K i for A1 8.2 nM) was similarly potent and selective, while 8-(1-oxyl-2,2,6,6-tetramethylpiperidin-4-yl)-1,3-dipropylxanthine 11 (K i for A1 160 nM) exhibited significantly lower affinity for A1 adenosine receptors. 8-[4-(((1-Oxyl-2,2,6,6-tetramethylpiperidin-4-yl)amino)-2-oxoethoxy)phenyl]-1-propylxanthine 14, a 3-unsubstituted xanthine derivative, was found to be a potent A2B adenosine receptor antagonist (K i for A2B 48 nM) but also exhibited high affinity for A1 receptors (K i for A1 15.7 nM). An X-ray structure of compound 10 was obtained, confirming the proposed structure. The novel spin-labeled A1-selective or A1/A2B-nonselective adenosine receptor antagonists may become useful probes for biophysicochemical investigations of adenosine receptors in their membrane environment.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm049513x</identifier><identifier>PMID: 15771453</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Adenosine A1 Receptor Antagonists ; Adenosine A2 Receptor Antagonists ; Animals ; Binding, Competitive ; Biological and medical sciences ; Brain - drug effects ; Brain - metabolism ; Cell Line ; Cricetinae ; Cricetulus ; Crystallography, X-Ray ; Cyclic N-Oxides - chemical synthesis ; Cyclic N-Oxides - chemistry ; Cyclic N-Oxides - pharmacology ; Cyclopentanes - chemical synthesis ; Cyclopentanes - chemistry ; Cyclopentanes - pharmacology ; Humans ; In Vitro Techniques ; Ligands ; Medical sciences ; Molecular Structure ; Neuropharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems ; Pharmacology. Drug treatments ; Purinergic P1 Receptor Antagonists ; Radioligand Assay ; Rats ; Receptor, Adenosine A1 - metabolism ; Receptor, Adenosine A2B - metabolism ; Receptors, Purinergic P1 - metabolism ; Spin Labels - chemical synthesis ; Structure-Activity Relationship ; Xanthines - chemical synthesis ; Xanthines - chemistry ; Xanthines - pharmacology</subject><ispartof>Journal of medicinal chemistry, 2005-03, Vol.48 (6), p.2108-2114</ispartof><rights>Copyright © 2005 American Chemical Society</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a381t-9a96fa87c6890d9c461fb44527233271e2f22a9cfc6775048c120d9ef04633a23</citedby><cites>FETCH-LOGICAL-a381t-9a96fa87c6890d9c461fb44527233271e2f22a9cfc6775048c120d9ef04633a23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16655413$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15771453$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ilaš, Janez</creatorcontrib><creatorcontrib>Pečar, Slavko</creatorcontrib><creatorcontrib>Hockemeyer, Jörg</creatorcontrib><creatorcontrib>Euler, Harald</creatorcontrib><creatorcontrib>Kirfel, Armin</creatorcontrib><creatorcontrib>Müller, Christa E</creatorcontrib><title>Development of Spin-Labeled Probes for Adenosine Receptors</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Functionalized xanthine derivatives bearing a nitroxide moiety at the 3- or 8-position were synthesized as electron paramagnetic resonance (EPR) probes. The 8-cyclopentyl-1-propylxanthine derivative 4, spin-labeled at N3 by substitution with a nitroxide-bearing dihydropyrrole moiety, was a potent and selective A1 adenosine receptor antagonist (K i for A1 5.5 nM, 1600-fold selectivity vs A2A, >200-fold vs A2B, and 310-fold vs A3 adenosine receptors). 8-(1-Oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)-1,3-dipropylxanthine 10 (K i for A1 8.2 nM) was similarly potent and selective, while 8-(1-oxyl-2,2,6,6-tetramethylpiperidin-4-yl)-1,3-dipropylxanthine 11 (K i for A1 160 nM) exhibited significantly lower affinity for A1 adenosine receptors. 8-[4-(((1-Oxyl-2,2,6,6-tetramethylpiperidin-4-yl)amino)-2-oxoethoxy)phenyl]-1-propylxanthine 14, a 3-unsubstituted xanthine derivative, was found to be a potent A2B adenosine receptor antagonist (K i for A2B 48 nM) but also exhibited high affinity for A1 receptors (K i for A1 15.7 nM). An X-ray structure of compound 10 was obtained, confirming the proposed structure. The novel spin-labeled A1-selective or A1/A2B-nonselective adenosine receptor antagonists may become useful probes for biophysicochemical investigations of adenosine receptors in their membrane environment.</description><subject>Adenosine A1 Receptor Antagonists</subject><subject>Adenosine A2 Receptor Antagonists</subject><subject>Animals</subject><subject>Binding, Competitive</subject><subject>Biological and medical sciences</subject><subject>Brain - drug effects</subject><subject>Brain - metabolism</subject><subject>Cell Line</subject><subject>Cricetinae</subject><subject>Cricetulus</subject><subject>Crystallography, X-Ray</subject><subject>Cyclic N-Oxides - chemical synthesis</subject><subject>Cyclic N-Oxides - chemistry</subject><subject>Cyclic N-Oxides - pharmacology</subject><subject>Cyclopentanes - chemical synthesis</subject><subject>Cyclopentanes - chemistry</subject><subject>Cyclopentanes - pharmacology</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>Ligands</subject><subject>Medical sciences</subject><subject>Molecular Structure</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems</subject><subject>Pharmacology. Drug treatments</subject><subject>Purinergic P1 Receptor Antagonists</subject><subject>Radioligand Assay</subject><subject>Rats</subject><subject>Receptor, Adenosine A1 - metabolism</subject><subject>Receptor, Adenosine A2B - metabolism</subject><subject>Receptors, Purinergic P1 - metabolism</subject><subject>Spin Labels - chemical synthesis</subject><subject>Structure-Activity Relationship</subject><subject>Xanthines - chemical synthesis</subject><subject>Xanthines - chemistry</subject><subject>Xanthines - pharmacology</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNpt0EtLw0AUBeBBFFsfC_-AZKPgIjrvSdwV31LR2orLYTq9A6lJJs6kov_eSEu7cXUX9-NwOAgdEXxOMCUX8wrzXBD2vYX6RFCc8gzzbdTHmNKUSsp6aC_GOcaYEcp2UY8IpQgXrI8ur-ELSt9UULeJd8m4Kep0aKZQwix5CX4KMXE-JIMZ1D4WNSSvYKFpfYgHaMeZMsLh6u6jt9ubydV9Ony-e7gaDFPDMtKmucmlM5myMsvxLLdcEjflXFBFGaOKAHWUmtw6K5USmGeW0M6Bw1wyZijbR6fL3Cb4zwXEVldFtFCWpga_iFoqQTOBRQfPltAGH2MAp5tQVCb8aIL131B6PVRnj1ehi2kFs41cLdOBkxUw0ZrSBVPbIm6clEJw8ufSpStiC9_rvwkfXTGmhJ68jPXkKX8c3Y9y_b7JNTbquV-Eutvun4K_1Z-JMQ</recordid><startdate>20050324</startdate><enddate>20050324</enddate><creator>Ilaš, Janez</creator><creator>Pečar, Slavko</creator><creator>Hockemeyer, Jörg</creator><creator>Euler, Harald</creator><creator>Kirfel, Armin</creator><creator>Müller, Christa E</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20050324</creationdate><title>Development of Spin-Labeled Probes for Adenosine Receptors</title><author>Ilaš, Janez ; Pečar, Slavko ; Hockemeyer, Jörg ; Euler, Harald ; Kirfel, Armin ; Müller, Christa E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a381t-9a96fa87c6890d9c461fb44527233271e2f22a9cfc6775048c120d9ef04633a23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adenosine A1 Receptor Antagonists</topic><topic>Adenosine A2 Receptor Antagonists</topic><topic>Animals</topic><topic>Binding, Competitive</topic><topic>Biological and medical sciences</topic><topic>Brain - drug effects</topic><topic>Brain - metabolism</topic><topic>Cell Line</topic><topic>Cricetinae</topic><topic>Cricetulus</topic><topic>Crystallography, X-Ray</topic><topic>Cyclic N-Oxides - chemical synthesis</topic><topic>Cyclic N-Oxides - chemistry</topic><topic>Cyclic N-Oxides - pharmacology</topic><topic>Cyclopentanes - chemical synthesis</topic><topic>Cyclopentanes - chemistry</topic><topic>Cyclopentanes - pharmacology</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>Ligands</topic><topic>Medical sciences</topic><topic>Molecular Structure</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems</topic><topic>Pharmacology. Drug treatments</topic><topic>Purinergic P1 Receptor Antagonists</topic><topic>Radioligand Assay</topic><topic>Rats</topic><topic>Receptor, Adenosine A1 - metabolism</topic><topic>Receptor, Adenosine A2B - metabolism</topic><topic>Receptors, Purinergic P1 - metabolism</topic><topic>Spin Labels - chemical synthesis</topic><topic>Structure-Activity Relationship</topic><topic>Xanthines - chemical synthesis</topic><topic>Xanthines - chemistry</topic><topic>Xanthines - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ilaš, Janez</creatorcontrib><creatorcontrib>Pečar, Slavko</creatorcontrib><creatorcontrib>Hockemeyer, Jörg</creatorcontrib><creatorcontrib>Euler, Harald</creatorcontrib><creatorcontrib>Kirfel, Armin</creatorcontrib><creatorcontrib>Müller, Christa E</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ilaš, Janez</au><au>Pečar, Slavko</au><au>Hockemeyer, Jörg</au><au>Euler, Harald</au><au>Kirfel, Armin</au><au>Müller, Christa E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development of Spin-Labeled Probes for Adenosine Receptors</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2005-03-24</date><risdate>2005</risdate><volume>48</volume><issue>6</issue><spage>2108</spage><epage>2114</epage><pages>2108-2114</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>Functionalized xanthine derivatives bearing a nitroxide moiety at the 3- or 8-position were synthesized as electron paramagnetic resonance (EPR) probes. The 8-cyclopentyl-1-propylxanthine derivative 4, spin-labeled at N3 by substitution with a nitroxide-bearing dihydropyrrole moiety, was a potent and selective A1 adenosine receptor antagonist (K i for A1 5.5 nM, 1600-fold selectivity vs A2A, >200-fold vs A2B, and 310-fold vs A3 adenosine receptors). 8-(1-Oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)-1,3-dipropylxanthine 10 (K i for A1 8.2 nM) was similarly potent and selective, while 8-(1-oxyl-2,2,6,6-tetramethylpiperidin-4-yl)-1,3-dipropylxanthine 11 (K i for A1 160 nM) exhibited significantly lower affinity for A1 adenosine receptors. 8-[4-(((1-Oxyl-2,2,6,6-tetramethylpiperidin-4-yl)amino)-2-oxoethoxy)phenyl]-1-propylxanthine 14, a 3-unsubstituted xanthine derivative, was found to be a potent A2B adenosine receptor antagonist (K i for A2B 48 nM) but also exhibited high affinity for A1 receptors (K i for A1 15.7 nM). An X-ray structure of compound 10 was obtained, confirming the proposed structure. The novel spin-labeled A1-selective or A1/A2B-nonselective adenosine receptor antagonists may become useful probes for biophysicochemical investigations of adenosine receptors in their membrane environment.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>15771453</pmid><doi>10.1021/jm049513x</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-2623 |
ispartof | Journal of medicinal chemistry, 2005-03, Vol.48 (6), p.2108-2114 |
issn | 0022-2623 1520-4804 |
language | eng |
recordid | cdi_proquest_miscellaneous_67528505 |
source | American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list) |
subjects | Adenosine A1 Receptor Antagonists Adenosine A2 Receptor Antagonists Animals Binding, Competitive Biological and medical sciences Brain - drug effects Brain - metabolism Cell Line Cricetinae Cricetulus Crystallography, X-Ray Cyclic N-Oxides - chemical synthesis Cyclic N-Oxides - chemistry Cyclic N-Oxides - pharmacology Cyclopentanes - chemical synthesis Cyclopentanes - chemistry Cyclopentanes - pharmacology Humans In Vitro Techniques Ligands Medical sciences Molecular Structure Neuropharmacology Neurotransmitters. Neurotransmission. Receptors Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems Pharmacology. Drug treatments Purinergic P1 Receptor Antagonists Radioligand Assay Rats Receptor, Adenosine A1 - metabolism Receptor, Adenosine A2B - metabolism Receptors, Purinergic P1 - metabolism Spin Labels - chemical synthesis Structure-Activity Relationship Xanthines - chemical synthesis Xanthines - chemistry Xanthines - pharmacology |
title | Development of Spin-Labeled Probes for Adenosine Receptors |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T11%3A22%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20of%20Spin-Labeled%20Probes%20for%20Adenosine%20Receptors&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Ila%C5%A1,%20Janez&rft.date=2005-03-24&rft.volume=48&rft.issue=6&rft.spage=2108&rft.epage=2114&rft.pages=2108-2114&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm049513x&rft_dat=%3Cproquest_cross%3E67528505%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a381t-9a96fa87c6890d9c461fb44527233271e2f22a9cfc6775048c120d9ef04633a23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=67528505&rft_id=info:pmid/15771453&rfr_iscdi=true |